(INH) Indus Holding - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0006200108
INH: Energy, Technology, Manufacturing, Medical, Logistics, Automation
INDUS Holding AG is a German-based private equity firm established in 1989, specializing in mergers and acquisitions, corporate spin-offs, and long-term investments in medium-sized manufacturing companies. The firm avoids investments in sectors such as retail, services, pure trading, consumer goods, and start-ups, focusing instead on industrial and technology-driven businesses. Its primary investment targets include companies in energy and environmental technology, infrastructure and logistics, automation, medical engineering, life sciences, and digitalization. INDUS Holding AG typically invests in small and medium-sized enterprises (SMEs) based in Germany, Switzerland, Austria, and other German-speaking regions of Europe, with annual sales ranging from €20 million to €100 million, an equity ratio above 30%, and double-digit EBIT margins. The firm prefers companies with minimal or no bank liabilities and seeks to acquire majority stakes, often leading to full ownership. INDUS Holding AG primarily targets owner-managed businesses and second-level acquisition opportunities, investing through its balance sheet.
From a technical perspective, the stock is currently trading above its SMA20 and SMA50 at €23.70, with an SMA200 of €22.22, suggesting potential short-term bullish momentum. The ATR of 0.46 indicates moderate volatility. On the fundamental side, the companys market cap of €604.91 million, forward P/E of 6.16, and P/B ratio of 0.81 suggest undervaluation relative to its earnings and book value. However, the RoE of 4.83% reflects room for improvement in profitability.
Over the next three months, INH is expected to experience short-term gains due to its position above key moving averages, supported by a low ATR indicating manageable risk. The attractive forward P/E and P/B ratios may attract investors, potentially driving price appreciation. However, the stocks position below its SMA200 suggests caution, as it may face resistance at higher levels. The low RoE could temper growth expectations, but the companys focus on industrial and technology sectors with strong fundamentals may offset this concern.
Additional Sources for INH Stock
INH Stock Overview
Market Cap in USD | 722m |
Sector | Industrials |
Industry | Conglomerates |
GiC Sub-Industry | Industrial Conglomerates |
IPO / Inception |
INH Stock Ratings
Growth 5y | -18.1% |
Fundamental | 10.9% |
Dividend | 49.3% |
Rel. Strength | -9.9 |
Analysts | - |
Fair Price Momentum | 25.00 EUR |
Fair Price DCF | 83.11 EUR |
INH Dividends
Dividend Yield 12m | 5.13% |
Yield on Cost 5y | 6.09% |
Annual Growth 5y | -5.59% |
Payout Consistency | 93.7% |
INH Growth Ratios
Growth Correlation 3m | 82.7% |
Growth Correlation 12m | -46.5% |
Growth Correlation 5y | -53% |
CAGR 5y | 4.50% |
CAGR/Max DD 5y | 0.09 |
Sharpe Ratio 12m | -0.14 |
Alpha | -16.25 |
Beta | 1.548 |
Volatility | 47.41% |
Current Volume | 36.9k |
Average Volume 20d | 87.5k |
As of April 02, 2025, the stock is trading at EUR 24.65 with a total of 36,896 shares traded.
Over the past week, the price has changed by -12.90%, over one month by +2.71%, over three months by +18.80% and over the past year by -3.13%.
Neither. Based on ValueRay Fundamental Analyses, Indus Holding is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.94 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INH as of April 2025 is 25.00. This means that INH is currently overvalued and has a potential downside of 1.42%.
Indus Holding has no consensus analysts rating.
According to ValueRays Forecast Model, INH Indus Holding will be worth about 27.3 in April 2026. The stock is currently trading at 24.65. This means that the stock has a potential upside of +10.83%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 32.3 | 31.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 27.3 | 10.8% |